Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |